世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

臨床診断薬市場規模、シェア、分析、検査別(肝臓パネル、脂質パネル、腎臓パネル、電解質検査、全血球数、感染症検査、その他)、製品別(試薬、機器、その他)、エンドユーザー別(診断ラボ、病院ラボ、ポイントオブケア検査、その他)、地域別予測、2022-2032年


Clinical Diagnostics Market Size, Share, and Analysis, By Test (Liver Panel, Lipid Panel, Renal Panel, Electrolyte Testing, Complete Blood Count, Infectious Disease Testing, Others), By Product (Reagents, Instruments, Others), By End User (Diagnostic Laboratory, Hospital Laboratory, Point-of-care Testing, Others) and Regional Forecasts, 2022-2032

臨床診断薬市場規模、シェア、分析、検査別(肝臓パネル、脂質パネル、腎臓パネル、電解質検査、全血球数、感染症検査、その他)、製品別(試薬、機器、その他)、エンドユーザー別(診断ラボ、病院ラボ、ポイン... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Fatpos Global
Fatpos グローバル
2023年10月31日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
304 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

臨床診断薬市場規模、シェア、分析、検査別(肝臓パネル、脂質パネル、腎臓パネル、電解質検査、全血球数、感染症検査、その他)、製品別(試薬、機器、その他)、エンドユーザー別(診断ラボ、病院ラボ、ポイントオブケア検査、その他)、地域別予測、2022-2032年

製品概要
臨床診断市場規模は2021年に668.6億米ドル、予測期間中のCAGRは6.6%を示し、2023年の759億米ドルから2032年には1,355億米ドルに成長すると予測される。
臨床診断サービスは、医師がさまざまな疾患の患者に必要な最善の治療法に関する意思決定を支援するさまざまな手段を提供する。慢性疾患や感染症の頻度は、自動化されたプラットフォームの導入とともに増加しており、市場成長を後押しすると予測されている。臨床診断は、患者の徴候、症状、身体検査を通じて病気を認識、特定、観察するプロセスを示す。多様な疾患を持つ患者の分類とともに、健康と幸福を増進するための疾患管理に役立つ。

市場ハイライト
臨床診断市場は、高血圧、糖尿病、心血管疾患のような疾病に罹患した不健康な習慣を持つ個人のライフスタイルの変化のような要因により、予測期間中にCAGR 6.6%で成長し、1,355億米ドルに達すると予想される。デジタル化の進展により、消費者は臨床結果に関与できるようになり、高い運用コスト削減効果が期待され、予測期間中の市場成長を後押しする。非侵襲的な出生前検査の受け入れの増加は、革新的なナノ材料の実装のための注目を作成し、市場成長のための需要を促進すると予想されるポイントオブケア医療診断。

臨床診断市場セグメント
- 検査
o 肝臓パネル
o 脂質パネル
o 腎臓パネル
o 電解質検査
o 完全血球計算
o 感染症検査
o その他
- 製品
o 試薬
機器
o その他
- エンドユーザー
診断ラボ
病院検査室
ポイントオブケア検査
その他

市場ダイナミクス
成長促進要因
臨床診断の需要増加が市場成長を促進する見込み
慢性疾患の罹患率の増加が市場の成長を促進する見込み
抑制要因
分子診断薬の容易な入手が市場の成長を抑制する可能性

主要プレイヤー
- バイオメリュー
- ARUPラボラトリーズ
- ベクトン・ディッキンソン社
- アボットラボラトリーズ
- キアゲン
- バイオリファレンスラボラトリーズ
- ラボコープ
- バイオサイエンティア・ヘルスケア
- ダナハーコーポレーション
- クエスト・ダイアグノスティックス
- ホロジック社
- F.ホフマン・ラ・ロシュAG
- サーモフィッシャーサイエンティフィック
- ソニックヘルスケア
- シスメックス株式会社
- シーメンス
- その他の著名なプレーヤー(会社概要、事業戦略、主要製品、財務実績、主要業績指標、リスク分析、最近の開発、地域プレゼンス、SWOT分析)

研究室用温度制御ユニットの世界市場はさらに地域別に分類されます:
- 北米市場規模、シェア、動向、機会、前年比成長率、CAG.R - 米国、カナダ
- 中南米市場規模、シェア、動向、機会、YoY成長率、CAGR - メキシコ、アルゼンチン、ブラジル、中南米の残りの地域
- ヨーロッパ市場規模、シェア、動向、機会、前年比成長率、CAGR - イギリス、フランス、ドイツ、イタリア、スペイン、ベルギー、ハンガリー、ルクセンブルク、オランダ、ポーランド、ノルディック、ロシア、トルコ、その他のヨーロッパ地域
- アジア太平洋地域の市場規模、シェア、動向、機会、前年比成長率、CAGR - インド, 中国, 韓国, 日本, マレーシア, インドネシア, ニュージーランド, オーストラリア, その他の地域
- 中東・アフリカ市場規模、シェア、動向、機会、前年比成長率、CAGR - 北アフリカ、イスラエル、GCC、南アフリカ、その他の地域

本レポートを購入する理由
- 経済的要因および非経済的要因の両方を含むセグメンテーションに基づく市場の定性的および定量的分析
- 各セグメントおよびサブセグメントの市場価値(10億米ドル)データの提供
- 市場の最速成長と支配が期待される地域とセグメントを表示
- 各地域における製品/サービスの消費を強調し、各地域の市場に影響を与えている要因を示す地域別分析
- 主要プレイヤーの市場ランキング、プロファイリングされた企業の過去5年間の新サービス/製品発売、提携、事業拡大、買収を盛り込んだ競争状況
- 主要市場プレイヤーの会社概要、企業洞察、製品ベンチマーク、SWOT分析からなる広範な企業プロフィール
- 新興地域と先進地域の両方の成長機会と促進要因、課題と阻害要因を含む最近の動向に関する業界の現在と将来の市場展望
- ポーターのファイブフォース分析による様々な観点からの市場の詳細分析
- バリューチェーンによる市場洞察の提供
- 市場ダイナミクスのシナリオと、今後数年間の市場の成長機会
- 販売後3ヶ月間のアナリストサポート


ページTOPに戻る


目次

1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Clinical Diagnostics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Clinical Diagnostics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Clinical Diagnostics Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Clinical Diagnostics Market
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Clinical Diagnostics Market Size & Forecast 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test
11.3.1.1. Liver Panel
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Lipid Panel
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Renal Panel
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Electrolyte Testing
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Complete Blood Count
11.3.1.5.1.By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6.Infectious Disease Testing
11.3.1.6.1.By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.7.Others
11.3.1.7.1.By Value (USD Million) 2022-2032F
11.3.1.7.2. Market Share (%) 2022-2032F
11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Product
11.3.2.1.Reagents
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Instruments
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3. By End User
11.3.3.1.Diagnostic Laboratory
11.3.3.1.1.By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Hospital Laboratory
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2.Market Share (%) 2022-2032F
11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Point-of-care Testing
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2.Market Share (%) 2022-2032F
11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Others
11.3.3.4.1. By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test
12.3.2.By Product
12.3.3.By End User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test
13.3.2.By Product
13.3.3.By End User
13.4. Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test
14.3.2.By Product
14.3.3.By End User
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test
15.3.2.By Product
15.3.3.By End User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Test
16.3.2.By Product
16.3.3.By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.BioMerieux
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. ARUP Laboratories
18.3. Becton, Dickinson, and Company
18.4.Abbott Laboratories
18.5. Qiagen
18.6. Bio-Reference Laboratories
18.7. Labcorp
18.8.Bioscientia Healthcare
18.9. Danaher Corporation
18.10.Quest Diagnostics Inc.
18.11.Hologic Inc.
18.12.F. Hoffmann-La Roche AG
18.13.Thermo Fisher Scientific
18.14.Sonic Healthcare Ltd
18.15.Sysmex Corporation
18.16. Siemens AG
18.17. Other Prominent Players
19. Appendix
20.Consultant Recommendation
1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Clinical Diagnostics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Clinical Diagnostics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Clinical Diagnostics Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Clinical Diagnostics Market
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Clinical Diagnostics Market Size & Forecast 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test
11.3.1.1. Liver Panel
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Lipid Panel
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Renal Panel
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Electrolyte Testing
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Complete Blood Count
11.3.1.5.1.By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6.Infectious Disease Testing
11.3.1.6.1.By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.7.Others
11.3.1.7.1.By Value (USD Million) 2022-2032F
11.3.1.7.2. Market Share (%) 2022-2032F
11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Product
11.3.2.1.Reagents
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Instruments
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3. By End User
11.3.3.1.Diagnostic Laboratory
11.3.3.1.1.By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Hospital Laboratory
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2.Market Share (%) 2022-2032F
11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Point-of-care Testing
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2.Market Share (%) 2022-2032F
11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Others
11.3.3.4.1. By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test
12.3.2.By Product
12.3.3.By End User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test
13.3.2.By Product
13.3.3.By End User
13.4. Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test
14.3.2.By Product
14.3.3.By End User
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test
15.3.2.By Product
15.3.3.By End User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Test
16.3.2.By Product
16.3.3.By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.BioMerieux
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. ARUP Laboratories
18.3. Becton, Dickinson, and Company
18.4.Abbott Laboratories
18.5. Qiagen
18.6. Bio-Reference Laboratories
18.7. Labcorp
18.8.Bioscientia Healthcare
18.9. Danaher Corporation
18.10.Quest Diagnostics Inc.
18.11.Hologic Inc.
18.12.F. Hoffmann-La Roche AG
18.13.Thermo Fisher Scientific
18.14.Sonic Healthcare Ltd
18.15.Sysmex Corporation
18.16. Siemens AG
18.17. Other Prominent Players
19. Appendix
20.Consultant Recommendation

 

ページTOPに戻る


 

Summary

Clinical Diagnostics Market Size, Share, and Analysis, By Test (Liver Panel, Lipid Panel, Renal Panel, Electrolyte Testing, Complete Blood Count, Infectious Disease Testing, Others), By Product (Reagents, Instruments, Others), By End User (Diagnostic Laboratory, Hospital Laboratory, Point-of-care Testing, Others) and Regional Forecasts, 2022-2032

PRODUCT OVERVIEW
Clinical Diagnostics Market size was USD 66.86 billion in 2021 and projected to grow from USD 75.9 billion in 2023 to USD 135.5 billion by 2032, exhibiting a CAGR of 6.6% during the forecast period.
Clinical diagnostic services give physicians a variety of instruments to aid in decision making related to best therapy required for patients with different diseases. The frequency of chronic and infectious diseases is increasing along with the implementation of automated platforms which is anticipated to boost the market growth. Clinical diagnostics denotes the process of recognising, identifying and observing disease through signs, symptoms, physical examination of a patient. They help in disease management to enhance health and well-being along with the classification of patients with diverse diseases.

MARKET HIGHLIGHTS
Clinical Diagnostics Market is expected to reach USD 135.5 billion, growing at a CAGR of 6.6% during forecast period owing to the factors like changing lifestyles of individuals with unhealthy habits, which resulted in acquiring diseases like hypertension, diabetes, and cardiovascular issues. Growing digital participation permit consumers to involve in clinical outcomes, high operational cost-cutting which is expected to boost the market growth during the forecast period. Increasing acceptance of non-invasive prenatal testing created attention for implementation of innovative nanomaterials, and point-of-care medical diagnostics which is anticipated to drive the demand for the market growth.

Clinical Diagnostics Market Segments:
• Test
o Liver Panel
o Lipid Panel
o Renal Panel
o Electrolyte Testing
o Complete Blood Count
o Infectious Disease Testing
o Others
• Product
o Reagents
o Instruments
o Others
• End User
o Diagnostic Laboratory
o Hospital Laboratory
o Point-of-care Testing
o Others

MARKET DYNAMICS
Growth Drivers
Increasing Demand for Clinical Diagnostic is Expected to Boost the Market Growth
Increasing Incidence of Chronic Diseases is Expected to Boost the Growth of the Market
Restraint
Easy Availability of Molecular Diagnostics May Restrain the Growth of the Market

Key Players
• BioMerieux
• ARUP Laboratories
• Becton, Dickinson, and Company
• Abbott Laboratories
• Qiagen
• Bio-Reference Laboratories
• Labcorp
• Bioscientia Healthcare
• Danaher Corporation
• Quest Diagnostics Inc.
• Hologic Inc.
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific
• Sonic Healthcare Ltd
• Sysmex Corporation
• Siemens AG
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:
• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 3-month post-sales analyst support.



ページTOPに戻る


Table of Contents

1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Clinical Diagnostics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Clinical Diagnostics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Clinical Diagnostics Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Clinical Diagnostics Market
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Clinical Diagnostics Market Size & Forecast 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test
11.3.1.1. Liver Panel
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Lipid Panel
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Renal Panel
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Electrolyte Testing
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Complete Blood Count
11.3.1.5.1.By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6.Infectious Disease Testing
11.3.1.6.1.By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.7.Others
11.3.1.7.1.By Value (USD Million) 2022-2032F
11.3.1.7.2. Market Share (%) 2022-2032F
11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Product
11.3.2.1.Reagents
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Instruments
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3. By End User
11.3.3.1.Diagnostic Laboratory
11.3.3.1.1.By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Hospital Laboratory
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2.Market Share (%) 2022-2032F
11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Point-of-care Testing
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2.Market Share (%) 2022-2032F
11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Others
11.3.3.4.1. By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test
12.3.2.By Product
12.3.3.By End User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test
13.3.2.By Product
13.3.3.By End User
13.4. Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test
14.3.2.By Product
14.3.3.By End User
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test
15.3.2.By Product
15.3.3.By End User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Test
16.3.2.By Product
16.3.3.By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.BioMerieux
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. ARUP Laboratories
18.3. Becton, Dickinson, and Company
18.4.Abbott Laboratories
18.5. Qiagen
18.6. Bio-Reference Laboratories
18.7. Labcorp
18.8.Bioscientia Healthcare
18.9. Danaher Corporation
18.10.Quest Diagnostics Inc.
18.11.Hologic Inc.
18.12.F. Hoffmann-La Roche AG
18.13.Thermo Fisher Scientific
18.14.Sonic Healthcare Ltd
18.15.Sysmex Corporation
18.16. Siemens AG
18.17. Other Prominent Players
19. Appendix
20.Consultant Recommendation
1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3. Clinical Diagnostics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Clinical Diagnostics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Clinical Diagnostics Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Clinical Diagnostics Market
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Clinical Diagnostics Market Size & Forecast 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Test
11.3.1.1. Liver Panel
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Lipid Panel
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Renal Panel
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Electrolyte Testing
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Complete Blood Count
11.3.1.5.1.By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6.Infectious Disease Testing
11.3.1.6.1.By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.7.Others
11.3.1.7.1.By Value (USD Million) 2022-2032F
11.3.1.7.2. Market Share (%) 2022-2032F
11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Product
11.3.2.1.Reagents
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Instruments
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3. By End User
11.3.3.1.Diagnostic Laboratory
11.3.3.1.1.By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Hospital Laboratory
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2.Market Share (%) 2022-2032F
11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Point-of-care Testing
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2.Market Share (%) 2022-2032F
11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Others
11.3.3.4.1. By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Test
12.3.2.By Product
12.3.3.By End User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Test
13.3.2.By Product
13.3.3.By End User
13.4. Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Test
14.3.2.By Product
14.3.3.By End User
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Test
15.3.2.By Product
15.3.3.By End User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Test
16.3.2.By Product
16.3.3.By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1.BioMerieux
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. ARUP Laboratories
18.3. Becton, Dickinson, and Company
18.4.Abbott Laboratories
18.5. Qiagen
18.6. Bio-Reference Laboratories
18.7. Labcorp
18.8.Bioscientia Healthcare
18.9. Danaher Corporation
18.10.Quest Diagnostics Inc.
18.11.Hologic Inc.
18.12.F. Hoffmann-La Roche AG
18.13.Thermo Fisher Scientific
18.14.Sonic Healthcare Ltd
18.15.Sysmex Corporation
18.16. Siemens AG
18.17. Other Prominent Players
19. Appendix
20.Consultant Recommendation

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

Fatpos Global社のヘルスケア分野での最新刊レポート

本レポートと同じKEY WORD(diagnostic)の最新刊レポート


よくあるご質問


Fatpos Global社はどのような調査会社ですか?


Fatpos Globalは経営コンサルティング、アドバイザリー、市場調査サービスを提供し、市場調査レポートを出版しているインドに主拠点をおく調査会社です。 Fatposは“Failures A... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る